Header Logo

Connection

Lawrence Kushi to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Lawrence Kushi has written about Treatment Outcome.
Lawrence Kushi
Connection Strength
0.566
Treatment Outcome
  1. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index. JAMA Oncol. 2015 Sep; 1(6):737-45.
    View in: PubMed
    Score: 0.098
  2. Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study. Breast Cancer Res Treat. 2011 Sep; 129(2):521-9.
    View in: PubMed
    Score: 0.073
  3. The Influence of Dietary Isothiocyanates on the Effectiveness of Mitomycin C and Bacillus Calmette-Gu?rin in Treating Nonmuscle-Invasive Bladder Cancer. J Urol. 2024 Sep; 212(3):420-430.
    View in: PubMed
    Score: 0.045
  4. The macrobiotic diet in cancer. J Nutr. 2001 11; 131(11 Suppl):3056S-64S.
    View in: PubMed
    Score: 0.038
  5. Material and psychological financial hardship related to employment disruption among female adolescent and young adult cancer survivors. Cancer. 2020 01 01; 127(1):137-148.
    View in: PubMed
    Score: 0.033
  6. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
    View in: PubMed
    Score: 0.029
  7. Results of a community-based low-literacy nutrition education program. J Community Health. 1997 Oct; 22(5):325-41.
    View in: PubMed
    Score: 0.028
  8. A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL). Breast Cancer Res Treat. 2016 07; 158(1):127-138.
    View in: PubMed
    Score: 0.026
  9. Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer. J Oncol Pract. 2015 Sep; 11(5):356-62.
    View in: PubMed
    Score: 0.024
  10. Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer. Breast Cancer. 2014 Nov; 21(6):780-5.
    View in: PubMed
    Score: 0.023
  11. KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):91-101.
    View in: PubMed
    Score: 0.020
  12. Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network. Lung Cancer. 2012 Dec; 78(3):245-52.
    View in: PubMed
    Score: 0.020
  13. Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study. J Clin Oncol. 2012 Nov 01; 30(31):3800-9.
    View in: PubMed
    Score: 0.020
  14. The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy. Breast J. 2012 May-Jun; 18(3):203-13.
    View in: PubMed
    Score: 0.019
  15. Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist. 2012; 17(3):419-27.
    View in: PubMed
    Score: 0.019
  16. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer. 2012 Apr 15; 118(8):2048-58.
    View in: PubMed
    Score: 0.019
  17. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010 Sep 20; 28(27):4120-8.
    View in: PubMed
    Score: 0.017
  18. New developments in the epidemiology of cancer prognosis: traditional and molecular predictors of treatment response and survival. Cancer Epidemiol Biomarkers Prev. 2006 Nov; 15(11):2042-6.
    View in: PubMed
    Score: 0.013

© 2025 Kaiser Permanente